Tau PET Imaging in Atypical Dementias
| Status: | Recruiting |
|---|---|
| Conditions: | Alzheimer Disease, Neurology, Neurology, Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 20 - 100 |
| Updated: | 6/10/2018 |
| Start Date: | February 2016 |
| End Date: | February 1, 2023 |
| Contact: | Christina Coventry, MS, RN |
| Email: | christina.coventry@northwestern.edu |
| Phone: | 312-908-9681 |
The goal of this study is to demonstrate the feasibility of mapping tau pathology in subjects
with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and
to systematically document the extent and location of tau pathology in PPA patients in vivo
using the same techniques.
with Primary Progressive Aphasia, using PET protocol with F-AV-1451 (trade name AV-1451) and
to systematically document the extent and location of tau pathology in PPA patients in vivo
using the same techniques.
Inclusion Criteria:
- Must have primary progressive aphasia
Exclusion Criteria:
- Pregnancy
- Breastfeeding
- Receiving radiation clinically
We found this trial at
1
site
Chicago, Illinois 60611
Principal Investigator: Emily Rogalski, Ph.D.
Phone: 312-908-9681
Click here to add this to my saved trials
